Lavipharm Company Description

Lavipharm S.A. engages in the research, development, manufacture, import, marketing, sale, and wholesale of pharmaceutical, cosmetics, and healthcare products to physicians and pharmacists in Greece and internationally.

The company offers pharmaceutical products for cardiology, oncology-urology, central nervous system, chronic pain, and self- treatment.

It also provides prescription medicines and over the counter (OTC) products, as well as LIFELAB CBD products.

The company was founded in 1911 and is based in Paiania, Greece.

Lavipharm S.A.

Country	Greece
Founded	1911
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	299
CEO	Telemaque Lavidas

Contact Details

Address: 12, Agias Marinas Street Paiania, 19002 Greece
Phone	30 210 66 91 000
Website	lavipharm.com

Stock Details

Ticker Symbol	LAVI
Exchange	Athens Stock Exchange
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	GRS246073001
SIC Code	2834

Key Executives

Name	Position
Panagiotis Giannouleas	Deputy Chief Executive Officer and Director
Telemaque Jean Lavidas	Chief Executive Officer and Executive Board Member
Vassilis Baloumis	Group Chief Financial Officer and Investor Relations Officer
Evangelos Paterakis	Chief Accountant
Eleana Nikolopoulou	Director of Legal and Compliance and Corporate Secretary
Ilias Konstantopoulos	Director of Marketing and Sales CHC
Mariza Antonaki	Human Resources Director
Dr. Katerina Tsardaka	Director of Business Development and Acquisitions
Dr. Emmanouil Petrou	Head of Medical Affairs of Lavipharm Hellas
Ioannis Sarigiannidis	Chief Commercial Officer International